📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
50
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
58%
💰 Capital Raise
75%
• Critical: only 0.7 months cash remaining
• Active shelf registration ($6M, 22% of market cap)
📉 Score Deterioration
50%
• Score rose 26 points recently (worsening)
• Score in HIGH risk zone (73/100)
🔄 Reverse Split
30%
• 52-week low $0.93 has breached $1
• Only 1 months cash — financial pressure
💹 Market Data
Market Cap$27.29M
Shares Outstanding15.16M
Float6.43M
Cash$683.5K
Debt$20.64M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest412
Days to Cover1.0
% of Float0.0%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Dec 31, 2018
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CDIX
📊 CDIX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CDIX Signal Convergence & Dark Pool Activity — StonkWhisper
📄 CDIX Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.